Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

CBD gummies are easy to dose, portable, and discreet. They also come in various flavors, making them a good choice for people new to CBD. Not to mention, they can be beneficial for various health ...

Lilly's arch-rival in the diabetes category Novo Nordisk is working on its own glucose-sending insulin platform, acquired via its $800 million acquisition of UK biotech Ziylo in 2018.

PCE inflation rises 2.5% year-on-year in January, meeting estimates By Investing.com - Feb 28, 2025 10 Investing.com - U.S. inflation matched the prior month's pace and slowed on an annualized ...

Collector M. Pradeep Kumar distributed the aids to the children. Diabetic patients were given insulin pens for both long-acting and ultra-short-acting insulin, insulators, and glucometers with 100 ...

Investing.com - Eli Lilly (NYSE:LLY) announced on Tuesday that it would begin selling 7.5 milligram and 10 milligram single-dose vials of its Zepbound weight-loss drug at a roughly $150 discount to ...

American pharmaceutical company Eli Lilly has started selling higher doses of its popular weight-loss drug Zepbound in vials, at a $150 discount to the cost of the injector pen versions.